CTGF is elevated in advanced stages of breast cancer, promotes mesenchymal features in MCF-7 cells when overexpressed, and is an upstream inducer of S100A4, a gene important for its positive effects on cell migration [78]. This evidence concerns the gene CCN2 and breast carcinoma.